Cadmium and prostate cancer

A critical epidemiologic analysis

Abe E. Sahmoun, L. Douglas Case, Sharon A. Jackson, Gary G. Schwartz, Gary Schwartz

Research output: Contribution to journalReview article

75 Citations (Scopus)

Abstract

Laboratory data implicate cadmium as a prostate carcinogen. However, epidemiological studies concerning the association between cadmium and prostate cancer are inconclusive. This article reviews the epidemiological literature on cadmium and prostate cancer with a special focus on highly exposed occupational cohorts. We searched the MEDLINE database from 1966 to 2002 for articles on cadmium and prostate cancer. All published analytical and descriptive studies that included relevant data were reviewed. In addition, we reviewed the experience of cohorts highly exposed to cadmium in nickel-cadmium battery plants. Of 4 descriptive studies, 3 reported a positive association between cadmium and prostate cancer. Of 10 case-control studies, 5 (50%) reported a positive association. Of 11 cohorts studies, 3 (33%) found a positive association. Finally, 4 studies on cohorts exposed in occupational nickel-cadmium batteries were identified and analyzed. The summary score of the standardized mortality ratios (SMRs) was weakly but not significantly positive 126 (95% confidence interval C.I.: 83-184). In contrast to laboratory studies, epidemiological studies do not convincingly implicate cadmium as a cause of prostate cancer. Future epidemiological studies that attempt to resolve the discrepancy between laboratory and epidemiological studies of cadmium carcinogenesis may benefit from incorporating biological measures of cadmium exposure.

Original languageEnglish (US)
Pages (from-to)256-263
Number of pages8
JournalCancer Investigation
Volume23
Issue number3
DOIs
StatePublished - Jun 15 2005

Fingerprint

Cadmium
Prostatic Neoplasms
Epidemiologic Studies
Nickel
Cohort Studies
MEDLINE
Carcinogens
Case-Control Studies
Prostate
Carcinogenesis
Databases
Confidence Intervals
Mortality

Keywords

  • Cadmium
  • Epidemiology
  • Occupation
  • Prostate cancer
  • Smoking

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Cadmium and prostate cancer : A critical epidemiologic analysis. / Sahmoun, Abe E.; Case, L. Douglas; Jackson, Sharon A.; Schwartz, Gary G.; Schwartz, Gary.

In: Cancer Investigation, Vol. 23, No. 3, 15.06.2005, p. 256-263.

Research output: Contribution to journalReview article

Sahmoun, AE, Case, LD, Jackson, SA, Schwartz, GG & Schwartz, G 2005, 'Cadmium and prostate cancer: A critical epidemiologic analysis', Cancer Investigation, vol. 23, no. 3, pp. 256-263. https://doi.org/10.1081/CNV-200055968
Sahmoun, Abe E. ; Case, L. Douglas ; Jackson, Sharon A. ; Schwartz, Gary G. ; Schwartz, Gary. / Cadmium and prostate cancer : A critical epidemiologic analysis. In: Cancer Investigation. 2005 ; Vol. 23, No. 3. pp. 256-263.
@article{c4543019b5c644a6b2e50c59d99677f2,
title = "Cadmium and prostate cancer: A critical epidemiologic analysis",
abstract = "Laboratory data implicate cadmium as a prostate carcinogen. However, epidemiological studies concerning the association between cadmium and prostate cancer are inconclusive. This article reviews the epidemiological literature on cadmium and prostate cancer with a special focus on highly exposed occupational cohorts. We searched the MEDLINE database from 1966 to 2002 for articles on cadmium and prostate cancer. All published analytical and descriptive studies that included relevant data were reviewed. In addition, we reviewed the experience of cohorts highly exposed to cadmium in nickel-cadmium battery plants. Of 4 descriptive studies, 3 reported a positive association between cadmium and prostate cancer. Of 10 case-control studies, 5 (50{\%}) reported a positive association. Of 11 cohorts studies, 3 (33{\%}) found a positive association. Finally, 4 studies on cohorts exposed in occupational nickel-cadmium batteries were identified and analyzed. The summary score of the standardized mortality ratios (SMRs) was weakly but not significantly positive 126 (95{\%} confidence interval C.I.: 83-184). In contrast to laboratory studies, epidemiological studies do not convincingly implicate cadmium as a cause of prostate cancer. Future epidemiological studies that attempt to resolve the discrepancy between laboratory and epidemiological studies of cadmium carcinogenesis may benefit from incorporating biological measures of cadmium exposure.",
keywords = "Cadmium, Epidemiology, Occupation, Prostate cancer, Smoking",
author = "Sahmoun, {Abe E.} and Case, {L. Douglas} and Jackson, {Sharon A.} and Schwartz, {Gary G.} and Gary Schwartz",
year = "2005",
month = "6",
day = "15",
doi = "10.1081/CNV-200055968",
language = "English (US)",
volume = "23",
pages = "256--263",
journal = "Cancer Investigation",
issn = "0735-7907",
publisher = "Informa Healthcare",
number = "3",

}

TY - JOUR

T1 - Cadmium and prostate cancer

T2 - A critical epidemiologic analysis

AU - Sahmoun, Abe E.

AU - Case, L. Douglas

AU - Jackson, Sharon A.

AU - Schwartz, Gary G.

AU - Schwartz, Gary

PY - 2005/6/15

Y1 - 2005/6/15

N2 - Laboratory data implicate cadmium as a prostate carcinogen. However, epidemiological studies concerning the association between cadmium and prostate cancer are inconclusive. This article reviews the epidemiological literature on cadmium and prostate cancer with a special focus on highly exposed occupational cohorts. We searched the MEDLINE database from 1966 to 2002 for articles on cadmium and prostate cancer. All published analytical and descriptive studies that included relevant data were reviewed. In addition, we reviewed the experience of cohorts highly exposed to cadmium in nickel-cadmium battery plants. Of 4 descriptive studies, 3 reported a positive association between cadmium and prostate cancer. Of 10 case-control studies, 5 (50%) reported a positive association. Of 11 cohorts studies, 3 (33%) found a positive association. Finally, 4 studies on cohorts exposed in occupational nickel-cadmium batteries were identified and analyzed. The summary score of the standardized mortality ratios (SMRs) was weakly but not significantly positive 126 (95% confidence interval C.I.: 83-184). In contrast to laboratory studies, epidemiological studies do not convincingly implicate cadmium as a cause of prostate cancer. Future epidemiological studies that attempt to resolve the discrepancy between laboratory and epidemiological studies of cadmium carcinogenesis may benefit from incorporating biological measures of cadmium exposure.

AB - Laboratory data implicate cadmium as a prostate carcinogen. However, epidemiological studies concerning the association between cadmium and prostate cancer are inconclusive. This article reviews the epidemiological literature on cadmium and prostate cancer with a special focus on highly exposed occupational cohorts. We searched the MEDLINE database from 1966 to 2002 for articles on cadmium and prostate cancer. All published analytical and descriptive studies that included relevant data were reviewed. In addition, we reviewed the experience of cohorts highly exposed to cadmium in nickel-cadmium battery plants. Of 4 descriptive studies, 3 reported a positive association between cadmium and prostate cancer. Of 10 case-control studies, 5 (50%) reported a positive association. Of 11 cohorts studies, 3 (33%) found a positive association. Finally, 4 studies on cohorts exposed in occupational nickel-cadmium batteries were identified and analyzed. The summary score of the standardized mortality ratios (SMRs) was weakly but not significantly positive 126 (95% confidence interval C.I.: 83-184). In contrast to laboratory studies, epidemiological studies do not convincingly implicate cadmium as a cause of prostate cancer. Future epidemiological studies that attempt to resolve the discrepancy between laboratory and epidemiological studies of cadmium carcinogenesis may benefit from incorporating biological measures of cadmium exposure.

KW - Cadmium

KW - Epidemiology

KW - Occupation

KW - Prostate cancer

KW - Smoking

UR - http://www.scopus.com/inward/record.url?scp=20044376703&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=20044376703&partnerID=8YFLogxK

U2 - 10.1081/CNV-200055968

DO - 10.1081/CNV-200055968

M3 - Review article

VL - 23

SP - 256

EP - 263

JO - Cancer Investigation

JF - Cancer Investigation

SN - 0735-7907

IS - 3

ER -